April 25, 2008 — /PRWEB/ — SAN JOSE, CA — Demand for faster and more economical ways to produce drugs for the pharmaceutical industry, proteomics, genomics, functional genomics, and combinatorial chemistry industries have led to the advancement of biotechnology instrumentation in recent years. Growth is likely to be supported by major technological innovations in almost all the sectors, especially in chip-based products. Innovations in DNA sequencers, including single-molecule detection technologies, are likely to increase read lengths, decrease out-of-phase chemistry issues, and simplify sample preparation processes. With several drugs set for patent expiration in the near future, enhanced research activity for development of new drugs has escalated the demand for electrophoresis instruments.

The United States and Europe collectively dominate the worldwide biotechnology instrumentation market with an estimated 70 percent share of sales in 2008 as stated by Global Industry Analysts, Inc. Focus is largely centered on development of more advanced, smaller, faster, and highly automated analytical instruments that integrate analytical technologies. In the United States, demand for advanced instruments with more throughput abilities is rising across all academic and pharmaceutical laboratories due to the shift of research focus towards proteomics. The protein/ peptide synthesizers market in the United States is projected to be the fastest growing segment.

Europe, Germany, the United Kingdom, and France represent the major markets, accounting for about a 55 percent share of the biotechnology instrumentation market. Germany occupies a pivotal position in the European biotech market. The DNA sequencers market in Germany is projected to reach $69 million by 2010. Asia-Pacific is expected to be the center of future growth in worldwide biotechnology instruments market with an impressive CAGR of 7 percent over the period 2000 to 2010. The HPLC equipment and supplies market in the region is estimated at $207 million for 2008.

Key players profiled in the report include Agilent Technologies Inc., Affymetrix, Applied Biosystems, Beckman Coulter, Bio-Rad Laboratories Inc., Dionex Corporation, GE HealthCare, Gilson Inc, Hitachi High-Technologies Corporation, Perkin-Elmer, Shimadzu Scientific Instruments Inc., Thermo Fisher Scientific Inc, Varian Inc., and Waters Corporation.

The report titled “Biotechnology Instrumentation: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., analyzes the market over the period 2000 to 2015. Product segments analyzed in the report include DNA synthesizers, protein/peptide synthesizers, DNA sequencers, protein/peptide sequencers, HPLC equipment and supplies, and electrophoresis equipment and supplies. The report reviews recent industry activity, technological innovations, and product introductions of major market participants across various segments.

Visit www.strategyr.com

April 25, 2008 — /PRWEB/ — SAN JOSE, CA — Enzymes are proteins with highly specialized catalytic functions produced by all living organisms. Enzymes play a major role in various aspects of life and are very important to the existence of life itself. Three-fourths of the ‘bulk’ consumption of enzymes is accounted for in the industries of food, starch processing, and detergent. Specialty enzymes are used in a host of medical applications and diagnostics, including testing of food products.

Asia-Pacific represents the fastest growing market for specialty enzymes, recording a CAGR of over 9 percent in the period 2000 to 2010 as stated by Global Industry Analysts, Inc. The specialty enzymes market in the U.S. is estimated at $1.1 billion. In terms of product segments, the global specialty medical enzymes market is expected to grow at a compounded annual rate of nearly 8.25 percent over the period 2000 to 2010. In Europe, demand for specialty enzymes in pharmaceuticals and diagnostics is projected to be worth $1.0 billion in 2012.

Protein engineering, gene expression, and similar advanced technologies aid in selective screening, modification, and manufacture of enzymes in large quantities. The enzyme market is undergoing a gradual transition from commodity-based to proprietary-based with specialty enzymes supporting novel applications and gradually narrowing down the distinction between industrial and specialty enzymes. Many major companies involved in enzyme production are endeavoring through various avant-garde technologies to progress in this direction. Companies in the biotechnology, chemical, and pharmaceutical industries are actively researching in this direction.

The report titled “Specialty Enzymes: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., provides a review of end-use markets, product overviews, product introductions/innovations, and recent industry activity. The study provides market analytics for the period 2000 to 2015 in value sales for the United States, Canada, Japan, Europe, Asia-Pacific, the Middle East, and Latin America. Product segments discussed include specialty medical enzymes, polymerases, nucleases, and other enzymes. End-use segments discussed are pharmaceuticals and diagnostics and research/biotechnology.

Market participants include Advanced Enzymes Technologies, Amano Enzyme, Aureozyme, Biocon, Biozyme Laboratories, Danisco, Genencor, Kinetic Biosystems, Maxygen, Codexis, Novozymes, Seravac Biotech, Specialty Enzymes and Biochemicals, and Verenium Corporation.

Visit www.strategyr.com

April 24, 2008 –

April 24, 2008 — /FDA/ — The U.S. Food and Drug Administration has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the southwestern United States.

Traditional latex gloves are made from the milky sap of a rubber tree, Hevea braziliensis. The sap contains a protein that may trigger allergic reactions, especially after prolonged and repeated contact. Sensitized people may experience mild reactions such as skin redness, rash, hives, or itching. More severe reactions may include respiratory symptoms such as difficulty breathing, coughing spells, and wheezing. Rarely, shock may occur.

Estimates vary, but anywhere from 3 percent to 22 percent of all health care workers are sensitized to traditional latex. Available data on the new guayule latex show that even people who are highly allergic to traditional latex do not react on first exposure to guayule latex proteins.

“This approval has the potential to make a significant difference to both the general public and the medical community at large,” says Daniel Schultz, M.D., director of FDA’s Center for Devices and Radiological Health. “Gloves made from guayule latex may prove to be a safer alternative for some people with sensitivity to traditional latex, and yet they will not sacrifice the desirable properties of traditional latex such as flexibility and strength.”

Health care workers first began using traditional latex gloves in the 1890s, but concerns about allergic reactions increased in the late 1980s after modifications in glove materials made them more sensitizing just as glove use was soaring in response to the HIV epidemic. Some health care institutions have since responded by shifting to alternative glove materials for their workers.

FDA has taken numerous steps to address the glove allergy problem including working with the industry to develop a consensus standard that identifies maximum protein and powder levels for medical gloves. A 1998 rule requires that all medical devices containing latex carry a statement on the label warning about the risk of allergic reactions. Because there is no data on people’s long-term experience with the Yulex glove, the product will carry a warning for now about the potential for allergic reactions.

The Yulex glove is made by the Yulex Corporation of Maricopa, AZ.

Visit www.fda.gov
www.yulex.com

April 24, 2008 — /PRWEB/ — SAN JOSE, CA — Filtration equipment is a critical component that finds numerous applications in laboratories. Europe and the United States dominate the global laboratory filtration equipment market, capturing an estimated 74 percent share in 2008 as stated in a recent report published by Global Industry Analysts, Inc. The filtration equipment market is expected to grow steadily with the introduction of new products as the market witnesses a transition from conventional methods of filtration to modern, sophisticated methods. The market is primarily dependent on research and development activities in the medical field for developing treatments for fatal diseases. The biotech industry is expected to be the major growth driver. Other driving forces for the market include increased use of microfiltration membranes in laboratory filtration applications and enhanced investment in research and development activities across various sectors.

Microfiltration products represent the largest and the fastest growing segment. The microfiltration products market in the United States is projected to reach $186 million by 2010. The laboratory/analytical market is a small, yet significant consumer of microfiltration membranes. The demand is usually for expensive, high-end membranes to be used in very critical processes. Europe represents the world’s largest market for laboratory filtration equipment and is poised to continue its superiority through 2010. The ultrafiltration products market in Europe is estimated at $147 million for 2008. Asia-Pacific, the developing world economy, is projected to register the highest growth rate during 2000 to 2010. The reverse osmosis market in the region is forecast to record sales of $7.5 million by 2010.

Leading players profiled in the report include Barnstead International, Cantel Medical Corp., Cuno, Inc., FilmTec Corp., GEA Filtration, GE Healthcare, GE Water & Process Technologies, Hydranautics, Koch Membrane Systems, Inc., Millipore Corp., Orbital Biosciences LLC, Pall Corp., Porex Corp., Sartorius Stedim Biotech SA, and Whatman Plc.

The report titled “Laboratory Filtration Equipment: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., analyzes the global and regional markets across three product segments, namely microfiltration products, reverse osmosis products, and ultrafiltration products. Analysis is presented for the United States, Canada, Japan, Europe, Asia-Pacific, and Latin America for the period 2000 to 2010. The report enumerates recent developments, mergers, acquisitions, and other strategic industry activities.

Visit www.strategyr.com

April 23, 2008 — /PRWEB/ — SAN JOSE, CA — Over the years, liquid chromatography has emerged as a workhorse technology in life sciences, pharmaceuticals, food and beverage, research and development, and industrial chemicals. Used alone or in combination with other high performance technologies, HPLC (high-performance liquid chromatography) is a versatile technique for efficient separation, quantification, and characterization of constituents of complex chemical mixtures. Present day HPLC devices are capable of analyzing almost all types of biological compounds, including small molecules that can be isolated or synthesized.

The United States and Europe comprise the major markets, collectively accounting for an estimated 70 percent share of the global HPLC systems and accessories market for 2008, as stated by Global Industry Analysts, Inc. Proliferation of new applications, especially in biotechnology and pharmaceutical sectors, is one of the major factors driving growth. Other drivers include integration with complementary techniques, or the growing shift towards “hyphenated technologies,” and growing acceptance and addition of new dimensions to the technique.

The HPLC columns market in the United States represents the largest market, with sales estimated at $303 million for 2008. Despite relatively mature conditions and resultant slow pace of growth, the HPLC market in United States is benefiting from the introduction of fast LC technologies. Fast LC systems offer various advantages to research laboratories, which include superior resolution, high sensitivity, and enhanced throughput.

The Asia-Pacific region is projected to record the fastest growth, posting a CAGR of 7.5 percent over the period 2000 to 2015. The HPLC market in countries such as India is expected to witness rapid growth propelled by an increase in life sciences research activities. The HPLC pumps market in the region is projected to reach $79 million by 2010.

Germany is one of the leading producers and consumers of analytical instrumentation and laboratory equipment in Europe. HPLC is a popular technique employed by the bioanalytical, chemical, and pharmaceutical industries in Germany. The HPLC sample injectors market in Germany is estimated at $45 million for 2008.

Key players profiled in the report include Agilent Life Sciences and Chemical Analysis Group, Dionex Corp., ESA Biosciences Inc., Hitachi High Technologies America, Jasco Corp., Knauer Scientific Instruments, Merck KgaA, Shimadzu Corp., Thermo Fisher Scientific Inc, Varian Inc., Waters Corp., and ZirChrom Separations Inc.

The report titled “HPLC Systems & Accessories: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., analyzes the market over the period 2000 to 2015. Analysis is presented for the United States, Canada, Japan, Europe, Asia-Pacific, and Latin America. Product segments analyzed include HPLC pumps, HPLC sample injectors, HPLC columns, HPLC detectors, fraction collectors, and accessories.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc. is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Visit www.strategyr.com

April 22, 2008 — /PRWEB/ — SAN JOSE, CA — Demand for disinfectant products is on the rise, driven by increasing health consciousness and hygiene awareness. General public awareness regarding problems associated with antibiotic-resistant bacteria and other infection causing agents has also contributed to market growth. Demand for disinfectants that sanitize food preparation surfaces is also growing, given the increased risk related to foodborne pathogens and other contaminants. Increased use of disinfectants aids in reducing infections including the reverse outbreak of diseases in hospitals and health clinics. In response to robust demand, manufacturers have introduced new and advanced products, including specialty disinfectants to satisfy varied needs of consumer and industrial users. Washing powders and liquids modified with disinfectants have also been introduced as a form of value addition to existing products. With the rise in antibiotic-resistant strains of bacteria, manufacturers are developing products customized for specific tasks.

The European disinfectants market, the largest in the world, is estimated at $1.13 billion for 2008 as stated by Global Industry Analysts, Inc. The Disinfectants market in Asia-Pacific is expected to grow fastest, registering a CAGR of 4.3 percent over the period 2001 to 2010. North America and Europe collectively account for over 80 percent of the world. In the U.S., demand for disinfectants in industrial processing is forecasted to record a CAGR of 3.8 percent over the period 2001 to 2010. Global market for disinfectants in pharma and health care industries is projected to reach over $330 million in 2015.

The global marketplace includes participants such as 3M Co., Ecolab, Henkel KGaA, JohnsonDiversey, Kao Corp, Procter and Gamble, Reckitt Benckiser, SC Johnson & Son, The Clorox Company, Unilever Plc, and Zep Inc.

“Disinfectants: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, product profile, players, competition, new product introductions, recent developments, mergers, acquisitions, alliances, and other strategic industry activities. Analysis is presented for major geographic markets such as the United States, Japan, France, Germany, the U.K., Italy, Asia, Latin America, and the Middle East. Analytics for the period 1991 to 2015 are provided in terms of delivery system including aerosols and non-aerosols, as well as by end-use segments including Industrial Processing, Pharma & Health Care, and Consumer & Other Applications.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc. is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Visit www.strategyr.com

April 21, 2008 — /SAN JOSE, CA/ — North America-based manufacturers of semiconductor equipment posted $1.16 billion in orders in March 2008 (three-month average basis) and a book-to-bill ratio of 0.89 according to the March 2008 Book-to-Bill Report published by SEMI. A book-to-bill of 0.89 means that $89 worth of orders were received for every $100 of product billed for the month.

The three-month average of worldwide bookings in March 2008 was $1.16 billion. The bookings figure is about four percent less than the final February 2008 level of $1.21 billion, and about 18 percent less than the $1.42 billion in orders posted in March 2007.

The three-month average of worldwide billings in March 2008 was $1.29 billion. The billings figure is about one percent less than the final February 2008 level of $1.31 billion, and about 10 percent less than the March 2007 billings level of $1.44 billion.

“Orders reported by North American equipment manufacturers have remained at relatively constant levels over the past six months,” says Dan Tracy, senior director of Industry Research and Statistics at SEMI. “This trend is a reflection of the uncertainty in the semiconductor industry and with current economic conditions.”

The SEMI book-to-bill is a ratio of three-month moving averages of worldwide bookings and billings for North American-based semiconductor equipment manufacturers.

Visit www.semi.org

April 16, 2008 — /PRNewswire/ — ATLANTA, GA — Murray’s Chicken, a family-run poultry processor based in southern Fallsburg, New York, is switching to electrolyzed water as its primary processing cleaning agent. Murray’s Chicken has signed a contract with EAU Technologies Inc. (BULLETIN BOARD: EAUI), a leading provider of electrolyzed water provided under the brand name Empowered Water^TM for high-volume, business-to-business applications, to use its technology in creating electrolyzed water for food sanitization at its processing facility. Murray’s Chicken will be the first poultry processor in the United States to utilize the technology on an industrial scale. Successful trials, including several at the University of Georgia, have shown that electrolyzed water is highly effective at killing food-borne bacteria such as Salmonella, E. Coli, and Listeria without affecting the quality of the food.